Hyfe

Name: Hyfe
Brand: Hyfe

AI Native

Transforming carbon we waste into the carbon we need.

Est 2021|Raised $13M|9 Ref Customers

LinkedIn 6K|Website|Web traffic 2K|FTEs 13|HQ San Francisco, California, US

01Competitive Landscape

Narrative analysis

- Hyfe vs VitaloJAK: Hyfe emphasizes automated counting without persistent raw audio capture, while VitaloJAK supports audio recording for manual review. Buyers should verify regulatory clearances and labeling claims directly with manufacturers and regulatory listings. - Hyfe vs platform ecosystems (ActiGraph): Hyfe has engaged in partnerships with platform providers to supply cough detection as a component within broader multisensor data collection. - Build vs buy: Some sponsors may develop internal cough algorithms; Hyfe's differentiators include published validation evidence and an operational deployment model that some sponsors may find useful.

	Hyfe (CoughMonitor Suite / CoughPro)	VitaloJAK (Vitalograph)	ActiGraph LEAP + Hyfe integration (platform approach)
Starting Price	Consumer subscription pricing (monthly or annual); B2B pricing available by quote	Quote-based; device/service oriented	Enterprise quote-based
Appropriate for	Continuous cough frequency endpoints and consumer cough tracking with a focus on automated event timestamps	Studies that require raw audio capture and workflows for manual verification and audit	Trials requiring multi-sensor endpoints (activity, sleep, vitals) with cough as one signal via a partner algorithm
Primary strengths	Automated continuous cough counts; published validation evidence; on-device processing with limited audio retention claims	Established presence in cough recording and human annotation workflows; suitable for audio-based audit	Platform maturity for multi-sensor data and established enterprise operational features
Primary limitations	Not cleared by the U.S. regulatory body for cough counting; enterprise pricing is opaque; consumer product strategy shifts create continuity concerns	Operational burden of raw audio review and manual annotation; potential regulatory differences in labeling/clearance	Cough capability depends on partner algorithms; platform-level complexity and cost for full deployments

01Competitive Landscape

Narrative analysis

Hyfe vs VitaloJAK: Hyfe emphasizes automated counting without persistent raw audio capture, while VitaloJAK supports audio recording for manual review. Buyers should verify regulatory clearances and labeling claims directly with manufacturers and regulatory listings.
Hyfe vs platform ecosystems (ActiGraph): Hyfe has engaged in partnerships with platform providers to supply cough detection as a component within broader multisensor data collection.
Build vs buy: Some sponsors may develop internal cough algorithms; Hyfe's differentiators include published validation evidence and an operational deployment model that some sponsors may find useful.

	Hyfe (CoughMonitor Suite / CoughPro)	VitaloJAK (Vitalograph)	ActiGraph LEAP + Hyfe integration (platform approach)
Starting Price	Consumer subscription pricing (monthly or annual); B2B pricing available by quote	Quote-based; device/service oriented	Enterprise quote-based
Appropriate for	Continuous cough frequency endpoints and consumer cough tracking with a focus on automated event timestamps	Studies that require raw audio capture and workflows for manual verification and audit	Trials requiring multi-sensor endpoints (activity, sleep, vitals) with cough as one signal via a partner algorithm
Primary strengths	Automated continuous cough counts; published validation evidence; on-device processing with limited audio retention claims	Established presence in cough recording and human annotation workflows; suitable for audio-based audit	Platform maturity for multi-sensor data and established enterprise operational features
Primary limitations	Not cleared by the U.S. regulatory body for cough counting; enterprise pricing is opaque; consumer product strategy shifts create continuity concerns	Operational burden of raw audio review and manual annotation; potential regulatory differences in labeling/clearance	Cough capability depends on partner algorithms; platform-level complexity and cost for full deployments

Hyfe

01Competitive Landscape

Narrative analysis

02Market Map

01Competitive Landscape

Narrative analysis

02Market Map